Immunogenicity and Safety of a Rabies Vaccine (Serum-free Vero Cell), Freeze-dried in Comparison With Verorab®, in a Pre-exposure Prophylaxis Regimen in Healthy Populations Aged ≥1 Years: A Randomized, Double-Blind, Active-controlled Phase Ⅲ Clinical Trial

To demonstrate the immunogenicity of Sinovac rabies vaccine is non-inferior to the active-controlled rabies vaccine (Verorab®) after pre-exposure prophylaxis (PrEP) vaccination, and to confirm its satisfying safety profile in the pediatric and adult population in a PrEP schedule

开始日期2026-03-01

申办/合作机构

北京科兴生物制品有限公司

NCT07055893

/ Not yet recruiting临床3期

Immunogenicity and Safety of a Rabies Vaccine (Serum-free Vero Cell), Freeze-dried in Comparison With Verorab®, in a Simulated Post-exposure Prophylaxis Regimen in Healthy Populations Aged ≥1 Years: A Randomized, Double-Blind, Active-controlled Phase Ⅲ Clinical Trial

To demonstrate the immunogenicity of Sinovac rabies vaccine is non-inferior to the active-controlled rabies vaccine (Verorab®) after post-exposure prophylaxis (PEP) vaccination, and to confirm its satisfying safety profile in the pediatric and adult population in a PEP schedule

开始日期2026-03-01

申办/合作机构

北京科兴生物制品有限公司

NCT07055880

/ Not yet recruiting临床2期

Immunogenicity and Safety of Two Dosages of Rabies Vaccine (Serum-free Vero Cell), Freeze-dried in Comparison With Verorab®, in a Simulated Post-exposure Prophylaxis Regimen in Healthy Adults: A Randomized, Double-Blind, Active-controlled Phase Ⅱ Clinical Trial

To describe the immunogenicity and safety of two dosages of Sinovac rabies vaccine, as well as compared the differences with the marked WHO PQ rabies vaccine Verorab® in a post-exposure prophylaxis (PEP) schedule.

开始日期2025-07-28

申办/合作机构

北京科兴生物制品有限公司

100 项与冻干人用狂犬病疫苗（无血清Vero细胞）（科兴）相关的临床结果

登录后查看更多信息

100 项与冻干人用狂犬病疫苗（无血清Vero细胞）（科兴）相关的转化医学

登录后查看更多信息

100 项与冻干人用狂犬病疫苗（无血清Vero细胞）（科兴）相关的专利（医药）

登录后查看更多信息

100 项与冻干人用狂犬病疫苗（无血清Vero细胞）（科兴）相关的药物交易

登录后查看更多信息